New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity on the long-term health of blood-making stem cells (hematopoietic stem cells).
About half of all cases of deafness are caused by genetic defects. So it’s no surprise that the emerging gene-editing technique CRISPR-Cas9 is being examined closely for its potential to prevent hearing loss in people who inherit those genes. Scientists at the Howard Hughes Medical Institute are among those looking to deploy CRISPR in genetic deafness—and they have their first evidence that their technique may hold promise.
New US research has found that being married may have a protective effect for patients who have suspected or confirmed heart disease, with those who are unmarried, divorced, or widowed all at a higher risk of death than married patients.
Short-term exposures to fine particulate air pollution and ozone—even at levels well below current national safety standards—were linked to higher risk of premature death among the elderly in the U.S. according to a new study from Harvard T.H. Chan School of Public Health.
The U.S. Food and Drug Administration (FDA) has issued new guidelines related to the 3D printing of medical devices. FDA is now preparing for a significant wave of new technologies that are nearly certain to transform medical practice.
Innovative data processing technologies allow for new form of medicine, called Personalized or Precision Medicine (PerMed), which is using information about a person’s genes, proteins, and environment to prevent, diagnose and treat diseases. Each type of cancer has its own genetic makeup, giving each tumor cell and tissue a unique character with specific tendencies and vulnerabilities.
A new paper-based sensor patch developed by researchers at Binghamton University, State University of New York could allow diabetics to effectively measure glucose levels during exercise.
Janssen has entered into a global collaboration and license agreement with Legend Biotech USA and Legend Biotech Ireland to develop, manufacture and commercialise experimental CART-cell therapy LCAR-B38M.
Irish biotechnology firm Shire has received 510(k) marketing clearance for its myPKFiT for ADVATE [Antihemophilic Factor (Recombinant)] software from the US Food and Drug Administration (FDA).
Seasonal flu kills between 291,000 and 646,000 people worldwide every year, a new analysis of data from 47 countries suggested Wednesday.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.